TScan Therapeutics
TCRX
#7495
Rank
S$0.36 B
Marketcap
$6.95
Share price
4.13%
Change (1 day)
13.48%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$3.93

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.80. In 2022 the company made an earnings per share (EPS) of -$3.61 a decrease over its 2021 EPS that were of -$2.86.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.938.78%
2022-$3.6126.25%
2021-$2.8699.58%
2020-$1.43